(Source: Diabetes News, 24 February 2011)
A new study has revealed that low-dose aspirin therapy could reduce the risk of atherosclerotic events in people suffering from type 2 diabetes that also have mild renal dysfunction. The research, by scientists in Japan and published in Diabetes Care, monitored 2,523 patients that were randomly put into two separate groups, with the first group receiving either 81 or 100 mg levels of aspirin each day, while the other group received no aspirin at all.
The scientists reviewed the groups for an average of 4.37 years, with fatal and non-fatal atherosclerotic ischemic heart disease, stroke and peripheral arterial disease being the primary end points in patients. Read more
0 comments:
Post a Comment